cnbc_topnews

Asia markets set to open mixed after Trump unveils plan to free ships in Hormuz

asia markets look set for a mixed open monday after trump announced "project freedom" — a plan to free ships stranded in the strait of hormuz. trump posted on truth social that the u.s. would attempt to free vessels affected by the closure since the start of the iran war. the effort begins monday middle east time, focusing on civilian ships flagged in non-conflict countries.

u.s. central command said support will include guided-missile destroyers, over 100 aircraft, multi-domain unmanned platforms, and 15,000 service members. oil prices dipped on the news: wti for july delivery fell 0.59% to $101.34, brent crude dropped 0.27% to $107.88.

hong kong's hang seng futures sat at 25,992 versus a last close of 25,776.53. australian futures were at 8,727, near the asx 200's close of 8,729.80. japan and china markets are closed for holidays. u.s. futures were near flat sunday night — s&p 500 up 0.1%, nasdaq 100 up 0.1%, dow up 100 points. on friday, the s&p 500 and nasdaq both hit new all-time highs, while the dow slipped 152.87 points.

source: cnbc_topnews
sentiment: -0.20 · impact: 0.70

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

source: marketwatch_top sentiment: -0.70 · impact: 0.80

Warsh's take on Fed independence is met with confusion and some concern

kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out

Read more

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

Warsh's take on Fed independence is met with confusion and some concern

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds